Marine Compounds and Cancer: 2017 Updates

Mar Drugs. 2018 Jan 24;16(2):41. doi: 10.3390/md16020041.

Sergey A Dyshlovoy^{1

2

3}, Friedemann Honecker^{4

5}

¹ Laboratory of Marine Natural Products Chemistry, G.B. Elyakov Pacific Institute of Bioorganic Chemistry, Far-East Branch, Russian Academy of Sciences, 690022 Vladivostok, Russia. dyshlovoy@gmail.com.
² Laboratory of Experimental Oncology, Department of Oncology, Hematology and Bone Marrow Transplantation with Section Pneumology, Hubertus Wald-Tumorzentrum, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany. dyshlovoy@gmail.com.
³ School of Natural Sciences, Far East Federal University, 690022 Vladivostok, Russia. dyshlovoy@gmail.com.
⁴ Laboratory of Experimental Oncology, Department of Oncology, Hematology and Bone Marrow Transplantation with Section Pneumology, Hubertus Wald-Tumorzentrum, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany. Friedemann.Honecker@zetup.ch.
⁵ Tumor and Breast Center ZeTuP St. Gallen, CH-9006 St. Gallen, Switzerland. Friedemann.Honecker@zetup.ch.

Abstract

By the end of 2017, there were seven marine-derived pharmaceutical substances that have been approved by the FDA for clinical use as drugs[...].